Diabetes care
Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes.
Abdulmohsen Bakhsh, Aman Saleemi, Dalton Budhram, Yucheng Zhang, Priya Bapat, Mohammad I Abuabat, Natasha J Verhoeff, Doug Mumford, Andrej Orszag, Michael Fralick, Alanna Weisman, Wajeeha Cheema, Mary Rose Waniss, Jean-Philippe Ouimet, George Tomlinson
Published: 202610.2337/dc25-1955
Abstract
OBJECTIVE: Sodium-glucose cotransporter inhibitors (SGLTi) in type 1 diabetes increase diabetic ketoacidosis (DKA) risk but may offer kidney protection. This study assesses whether a reduced estimated glomerular filtration rate (eGFR) increases DKA r…
Preview only. Read the full abstract at the source